Stock listing
LSE:0RK9 Alligator Bioscience AB Share Price
UK listing (LSE) of Alligator Bioscience AB · home listing Stockholm:ATORX
Follow Alligator Bioscience AB into a list and get an email when it puts out news.
Home listing price · OMXSTO:ATORX
0.0087 SEK +0.0001 (+1.2%)
Close on Nov 18, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:ATORX
- Day range
- 0.0086 – 0.0091 SEKNov 18, 2026
- Volume
- 10.15M sharesNov 18, 2026
- Market cap
- 31.04M SEKAt the close on Nov 18, 2026 · price × 3.57B shares outstanding
- 52-week range
- 0.0083 – 1.1298 SEKLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
- Traded on an average day
- 571,349 SEKMedian day 16.84M shares · last 3 months, Aug 18, 2026 – Nov 18, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Stockholm:ATORX · Home | 0.0087 SEK | +0.0001 (+1.2%) | 10,154,924 | 0.0086 | 0.0091 | 0.0086 | 0.0086 | Close on Nov 18, 2026 |
| Frankfurt:7AL0 | €0.0001 EUR | 0.0000 (0.0%) | — | €0.0001 | €0.0001 | €0.0001 | €0.0001 | Close on Nov 18, 2026 |
Daily closes
Last 3 months, Aug 18, 2026 – Nov 18, 2026 · OMXSTO:ATORX · SEK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 0.0087 | +0.0001 | +1.2% | 0.0086 | 0.0091 | 0.0086 | 10,154,924 | |
| 0.0086 | -0.0002 | -2.3% | 0.0088 | 0.0090 | 0.0083 | 12,239,481 | |
| 0.0088 | -0.0003 | -3.3% | 0.0093 | 0.0100 | 0.0087 | 34,118,189 | |
| 0.0091 | 0.0000 | 0.0% | 0.0091 | 0.0097 | 0.0089 | 9,658,943 | |
| 0.0091 | -0.0007 | -7.1% | 0.0100 | 0.0101 | 0.0089 | 43,339,388 | |
| 0.0098 | -0.0003 | -3.0% | 0.0100 | 0.0101 | 0.0096 | 18,387,106 | |
| 0.0101 | -0.0003 | -2.9% | 0.0107 | 0.0107 | 0.0099 | 40,957,360 | |
| 0.0104 | -0.0003 | -2.8% | 0.0108 | 0.0110 | 0.0103 | 56,605,464 | |
| 0.0107 | -0.0004 | -3.6% | 0.0112 | 0.0113 | 0.0102 | 87,815,616 | |
| 0.0111 | -0.0014 | -11.2% | 0.0128 | 0.0129 | 0.0107 | 141,789,162 | |
| 0.0125 | +0.0026 | +26.3% | 0.0187 | 0.0199 | 0.0117 | 535,017,989 | |
| 0.0099 | -0.0001 | -1.0% | 0.0101 | 0.0101 | 0.0098 | 6,107,124 | |
| 0.0100 | -0.0001 | -1.0% | 0.0100 | 0.0104 | 0.0097 | 20,770,846 | |
| 0.0101 | -0.0010 | -9.0% | 0.0111 | 0.0111 | 0.0097 | 46,645,799 | |
| 0.0111 | +0.0004 | +3.7% | 0.0108 | 0.0114 | 0.0103 | 51,704,703 | |
| 0.0107 | +0.0006 | +5.9% | 0.0101 | 0.0107 | 0.0098 | 32,065,794 | |
| 0.0101 | -0.0005 | -4.7% | 0.0108 | 0.0109 | 0.0096 | 124,637,325 | |
| 0.0106 | -0.0002 | -1.9% | 0.0109 | 0.0111 | 0.0099 | 63,474,371 | |
| 0.0108 | -0.0008 | -6.9% | 0.0121 | 0.0126 | 0.0108 | 32,693,949 | |
| 0.0116 | -0.0010 | -7.9% | 0.0129 | 0.0129 | 0.0114 | 44,026,390 | |
| 0.0126 | -0.0006 | -4.5% | 0.0133 | 0.0134 | 0.0126 | 6,815,229 | |
| 0.0132 | +0.0002 | +1.5% | 0.0128 | 0.0133 | 0.0126 | 22,150,075 | |
| 0.0130 | -0.0004 | -3.0% | 0.0135 | 0.0135 | 0.0127 | 12,509,086 | |
| 0.0134 | -0.0013 | -8.8% | 0.0150 | 0.0152 | 0.0130 | 75,997,507 | |
| 0.0147 | +0.0002 | +1.4% | 0.0146 | 0.0216 | 0.0145 | 92,561,964 | |
| 0.0145 | -0.0008 | -5.2% | 0.0155 | 0.0155 | 0.0145 | 11,712,187 | |
| 0.0153 | -0.0008 | -5.0% | 0.0157 | 0.0161 | 0.0153 | 10,382,603 | |
| 0.0161 | -0.0012 | -6.9% | 0.0173 | 0.0173 | 0.0153 | 29,633,664 | |
| 0.0173 | +0.0001 | +0.6% | 0.0175 | 0.0177 | 0.0160 | 10,196,727 | |
| 0.0172 | -0.0008 | -4.4% | 0.0188 | 0.0189 | 0.0172 | 5,124,857 | |
| 0.0180 | -0.0013 | -6.7% | 0.0199 | 0.0205 | 0.0180 | 15,525,797 | |
| 0.0193 | -0.0004 | -2.0% | 0.0207 | 0.0207 | 0.0192 | 1,612,698 | |
| 0.0197 | -0.0003 | -1.5% | 0.0200 | 0.0201 | 0.0190 | 3,543,122 | |
| 0.0200 | -0.0009 | -4.3% | 0.0209 | 0.0218 | 0.0194 | 16,005,292 | |
| 0.0209 | -0.0012 | -5.4% | 0.0228 | 0.0228 | 0.0201 | 4,916,576 | |
| 0.0221 | -0.0009 | -3.9% | 0.0232 | 0.0245 | 0.0217 | 15,111,387 | |
| 0.0230 | +0.0032 | +16.2% | 0.0198 | 0.0248 | 0.0198 | 35,046,932 | |
| 0.0198 | -0.0004 | -2.0% | 0.0205 | 0.0205 | 0.0195 | 2,657,451 | |
| 0.0202 | -0.0010 | -4.7% | 0.0213 | 0.0213 | 0.0196 | 7,350,637 | |
| 0.0212 | +0.0002 | +1.0% | 0.0210 | 0.0216 | 0.0202 | 4,516,403 | |
| 0.0210 | -0.0020 | -8.7% | 0.0231 | 0.0231 | 0.0201 | 18,977,716 | |
| 0.0230 | -0.0006 | -2.5% | 0.0239 | 0.0239 | 0.0214 | 8,263,185 | |
| 0.0236 | +0.0003 | +1.3% | 0.0240 | 0.0245 | 0.0225 | 3,163,888 | |
| 0.0233 | +0.0009 | +4.0% | 0.0221 | 0.0244 | 0.0214 | 10,361,355 | |
| 0.0224 | +0.0009 | +4.2% | 0.0215 | 0.0234 | 0.0208 | 10,024,366 | |
| 0.0215 | -0.0013 | -5.7% | 0.0229 | 0.0235 | 0.0212 | 4,188,776 | |
| 0.0228 | -0.0002 | -0.9% | 0.0231 | 0.0235 | 0.0224 | 5,365,387 | |
| 0.0230 | -0.0010 | -4.2% | 0.0240 | 0.0245 | 0.0227 | 4,060,089 | |
| 0.0240 | 0.0000 | 0.0% | 0.0247 | 0.0247 | 0.0222 | 16,793,301 | |
| 0.0240 | -0.0020 | -7.7% | 0.0265 | 0.0265 | 0.0240 | 12,644,828 | |
| 0.0260 | +0.0010 | +4.0% | 0.0257 | 0.0269 | 0.0251 | 22,424,924 | |
| 0.0250 | -0.0007 | -2.7% | 0.0260 | 0.0272 | 0.0247 | 24,731,673 | |
| 0.0257 | -0.0007 | -2.7% | 0.0264 | 0.0278 | 0.0251 | 17,206,620 | |
| 0.0264 | -0.0009 | -3.3% | 0.0276 | 0.0312 | 0.0245 | 36,082,633 | |
| 0.0273 | -0.0036 | -11.7% | 0.0305 | 0.0390 | 0.0251 | 119,458,977 | |
| 0.0309 | +0.0009 | +3.0% | 0.0320 | 0.0329 | 0.0301 | 13,357,519 | |
| 0.0300 | -0.0020 | -6.3% | 0.0311 | 0.0327 | 0.0290 | 16,841,369 | |
| 0.0320 | -0.0026 | -7.5% | 0.0344 | 0.0346 | 0.0300 | 20,641,711 | |
| 0.0346 | +0.0063 | +22.3% | 0.0290 | 0.0360 | 0.0290 | 58,741,072 | |
| 0.0283 | -0.0021 | -6.9% | 0.0304 | 0.0310 | 0.0283 | 13,187,890 | |
| 0.0304 | -0.0007 | -2.3% | 0.0310 | 0.0310 | 0.0297 | 3,782,883 | |
| 0.0311 | +0.0008 | +2.6% | 0.0320 | 0.0320 | 0.0298 | 12,461,341 | |
| 0.0303 | -0.0014 | -4.4% | 0.0327 | 0.0339 | 0.0291 | 18,688,403 | |
| 0.0317 | +0.0017 | +5.7% | 0.0304 | 0.0368 | 0.0290 | 37,615,807 | |
| 0.0300 | -0.0031 | -9.4% | 0.0331 | 0.0340 | 0.0294 | 28,377,503 |
Splits
4 splits since 2021 · OMXSTO:ATORX · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-1000 | Consolidation | |
| 33-for-20 | Split | |
| 1.0915-for-1 | Split | |
| 49-for-47 | Split |
- Ticker
- LSE:0RK9
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- LSE
- Currency
- SEK
What changed lately
Latest news release · Nov 13, 2026
Nomination Committee of Alligator Bioscience proposes new board and reduced fees ahead of extraordinary general meeting on 27 November 2026
Latest earnings call · Aug 26, 2026
Alligator Bioscience (Stockholm:ATORX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 15 slides
Calls
Replays
Alligator Bioscience (Stockholm:ATORX) Q2 2026 Earnings Call
Wed, Aug 26, 2026 · 9:00 AM ET
Watch TranscriptAlligator Bioscience (Stockholm:ATORX) Q1 2026 Earnings Call
Tue, May 05, 2026 · 7:00 AM ET
Watch TranscriptAlligator Bioscience (Stockholm:ATORX) Q4 2025 Earnings Call
Thu, Feb 12, 2026 · 9:00 AM ET
Watch Transcript
Latest news
Nomination Committee of Alligator Bioscience proposes new board and reduced fees ahead of extraordinary general meeting on 27 November 2026
Nov 13, 2026
Closed 0.0088 (-3.3%) on Nov 16, 2026
Alligator Bioscience appoints Johan Giléus as CEO – Søren Bregenholt to step down at year-end
Oct 4, 2026
Closed 0.018 (-6.7%) on Oct 5, 2026
Alligator Bioscience carries out a directed issue of warrants to Fenja Capital in connection with the completed rights issue
Sep 29, 2026
Closed 0.021 (-5.4%) on Sep 29, 2026
Alligator Bioscience announces final outcome in rights issue
Sep 22, 2026
Closed 0.02 (-4.7%) on Sep 23, 2026
Alligator Bioscience announces preliminary outcome in rights issue
Sep 21, 2026
Closed 0.021 (-8.7%) on Sep 21, 2026
Alligator Bioscience publishes prospectus in connection with rights issue
Aug 31, 2026
Closed 0.031 (+3.0%) on Aug 31, 2026
Bulletin from the Extraordinary General Meeting in Alligator Bioscience AB
Aug 26, 2026
Closed 0.035 (+22.3%) on Aug 26, 2026
Invitation to Alligator Bioscience's Earnings Call on 26 August 2026
Aug 20, 2026
Closed 0.03 (-4.4%) on Aug 20, 2026
Alligator discontinues independent development of mitazalimab for a strategic refocus on the HLX22 project, announces a rights issue of units of approximately SEK 125.6 million and raises bridge loans
Jul 23, 2026
Closed 0.05 (-74.0%) on Jul 23, 2026
Alligator announces first patient dosed in investigator-initiated study of intratumoral mitazalimab in early-stage breast cancer
Jul 2, 2026
Closed 0.173 (+1.9%) on Jul 2, 2026
Financings
Rights offering of units of ordinary shares and warrants series TO 15 and TO 16
Sep 22, 2026 · US$5.97M
Closed: SEK 58.8M raised · SEK 0.04 a unit · each unit consists of two ordinary shares, one warrant series TO 15 and one warrant… · APREA Partners AB +1
Dealers: APREA Partners AB, Vator Securities AB
Buyers: Roxette Photo S.A. (part of subscription undertakings totaling SEK 2 million); Søren Bregenholt (part of subscription undertakings totaling SEK 2 million); Vator Securities AB (guarantee commitments totaling SEK 56.8 million together with Mangold); Mangold Fondkommission AB (guarantee commitments totaling SEK 56.8 million together with Vator Securities)
Insiders: Existing shareholders including CEO Søren Bregenholt have entered into subscription undertakings totaling SEK 2 million
Use of proceeds: Repayment of bridge loans of SEK 19 million
Announced Jul 23, 2026 · Update Aug 26, 2026 · Update Aug 31, 2026 · Closed Sep 22, 2026
Warrant exercise of ordinary shares via exercise of warrants series TO 14
Feb 27, 2026 · US$5.43M
Announced: about SEK 49M · SEK 0.2 a share
Use of proceeds: General corporate purposes and loan repayment
Rights offering of units, each of two ordinary shares and one warrant series TO 14
Dec 19, 2025 · US$9.81M
Update: about SEK 91M · SEK 0.4 a unit · one (1) warrant series TO 14 per unit · Vator Securities AB +1
Dealers: Vator Securities AB (lead), Setterwalls Advokatbyrå AB
Buyers: Fenja Capital (guarantee commitment of SEK 30 million); Hans-Peter Ostler, Søren Bregenholt, Johan Giléus (intend to subscribe pro rata, approximately SEK 0.7 million in total); Roxette Photo SA (Additional subscription undertaking, part of approximately SEK 5.4 million in total); Magnus Petersson (Additional subscription undertaking, part of approximately SEK 5.4 million in total); HDF Impact BV (Top guarantee commitment, part of SEK 12.5 million in total)
Insiders: Subscription undertakings from existing major shareholders and certain members of the Board of Directors and management totalling approximately SEK 6 million
Use of proceeds: Issue costs, repayment of bridge loans and repayment of part of the outstanding loan to Fenja Capital II A/S
Announced Oct 22, 2025 · Update Oct 22, 2025 · Update Oct 23, 2025 · Update Nov 25, 2025 · Update Dec 1, 2025 · Update Dec 3, 2025 · Update Dec 19, 2025
Warrant exercise of ordinary shares via exercise of warrants series TO 13
Sep 17, 2025
Closed: SEK 28.1M in the latest tranche · SEK 3.12 a share · Vator Securities
Dealers: Vator Securities
Insiders: Chairman of the Board, CEO and CFO intend to exercise all of their TO 13, totalling approximately SEK 0.2 million
Use of proceeds: Loan repayment to Fenja Capital (50% of net proceeds) and general corporate purposes, supporting mitazalimab toward Phase 3 and a partnership
Announced Aug 27, 2025 · Update Sep 8, 2025 · Closed Sep 16, 2025 · Closed Sep 17, 2025
Warrant exercise of ordinary shares (directed issue to top guarantors of warrants series TO 12)
May 26, 2025
Closed: SEK 61.5M raised · SEK 3.68 a share · Vator Securities
Dealers: Vator Securities
Buyers: Roxette Photo SA (Subscription undertaking, part of approximately SEK 16.2 million in total undertakings); Fenja Capital II A/S (1,810,425 ordinary shares for SEK 6,662,364.00); Birger Jarl 2 AB (125,209 ordinary shares for SEK 460,769.12); Consentia Group AB (125,209 ordinary shares for SEK 460,769.12); Johan Carlström (125,209 ordinary shares for SEK 460,769.12); Ghanem Chouha (75,125 ordinary shares for SEK 276,460.00); Tony Chouha (75,125 ordinary shares for SEK 276,460.00); Ulti AB (75,125 ordinary shares for SEK 276,460.00); Bohr Invest AB (75,125 ordinary shares for SEK 276,460.00); Niclas Löwgren (62,604 ordinary shares for SEK 230,382.72); Stefan Hansson (62,604 ordinary shares for SEK 230,382.72); Great Ventures & Consulting GCV AB (62,604 ordinary shares for SEK 230,382.72); Axel Lindberg (56,344 ordinary shares for SEK 207,345.92)
Insiders: The Chairman of the Board, CEO and CFO gave subscription undertakings, part of approximately SEK 16.2 million in total undertakings
Use of proceeds: General corporate purposes, developing mitazalimab toward Phase 3, securing a mitazalimab partnership, and loan repayment
Announced Apr 28, 2025 · Update May 9, 2025 · Update May 20, 2025 · Closed May 26, 2025
Decks
Investor Presentation (September 2026)
Investor deck · 15 slides · September 2026
Q2 2026 Earnings Presentation
Earnings · 28 slides · Aug 26, 2026
Q1 2026 Earnings Presentation
Earnings · 28 slides · May 5, 2026
Investor Presentation (September 2025)
Investor deck · 32 slides · September 2025
Alligator Bioscience AB on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 35 in the last 12 months · 77 in all · newest Nov 13, 2026 · oldest 2025
- Calls
- 10 calls with a replay · 10 with a transcript · latest Aug 26, 2026
- Decks
- 17 decks · latest September 2026
Where Alligator Bioscience AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Stockholm:ATORX · Home listing | Stockholm | Sweden | SEK |
| LSE:0RK9 · This page | LSE | United Kingdom | SEK |
| LS Exchange:A41BED | LS Exchange | Germany | EUR |
| Lang & Schwarz:A41BED | Lang & Schwarz | Germany | EUR |
| Aquis:ATORXS | Aquis | United Kingdom | SEK |
| Frankfurt:7AL0 | Frankfurt | Germany | EUR |
| Aquis:ATORXS | Aquis | United Kingdom | SEK |
| Stuttgart:7AL0 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Alligator Bioscience AB.